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doi:10.1016/j.ejvs.2009.07.003Abstract Objectives: A feasibility study.
Methods: Eight pigs (all females; mean weight: 29 kg) underwent a conventional transperito-
neal aortic approach with implantation of an aorto-prosthetic end-to-side anastomosis using
a Clampless device and deployment of a 5-mm polytetrafluoroethylene (PTFE) graft. After
proximal ligature, a conventional end-to-end anastomosis was then performed between the
graft and the left iliac artery.
Results: The first pig died during the procedure due to graft misplacement. The seven other
procedures were successful with a mean operative and anastomosis time of 101 min (range:
81e115 min) and 3.35 min (range: 2.25e4.25 min), respectively; mean blood loss was 152 ml
(range: 30e235 ml). Another pig with a patent graft died at day 4 as a result of a severe unre-
lated pneumonopathy. The angiogram performed during the procedure and before sacrifice, at
2 (nZ 2), 4 (nZ 2) and 6 weeks (nZ 2), showed no graft stenosis or thrombosis. Microscopic
examination revealed a tissue covering the intraluminal stent, which evolved over time, with
no visible endothelial proliferation or inflammation.
Conclusion: An aorto-prosthetic anastomosis can be performed safely and efficiently with our
new clampless and sutureless device. The next step will be a laparoscopic Clampless implan-
tation.
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ty for Vascular Surgery. PublisheIn 2007, the TransAtlantic Society Consensus recommended
surgically performing a conventional aorto-bifemoral
bypass as the first choice for type D aorto-iliac occlusive
disease (AIOD) (a diffuse disease with severe stenoses ord by Elsevier Ltd. All rights reserved.
Figure 1 Drawing of the Clampless device implanted in the infra-renal aorta.
Figure 2 Clampless prototype implant. Small arrow: 7 mm
connector covered with a PTFE graft, deployed inside the
abdominal aorta. Large arrow: 5 mm PTFE graft, implanted in
the left iliac artery.
598 Y.S. Alimi et al.occlusion involving the aorta and both iliac arteries), and as
the preferred treatment for good-risk patients with type C
lesions (bilateral common iliac occlusion or severe and long
bilateral external iliac artery stenoses).1 However, these
bypasses are associated with a mortality rate of 0e3.3% and
a morbidity rate of 8.3e13%, mainly because of cardio-
respiratory complications.2,3 The two main explanations for
these severe complications are the long midline or flank
incisions needed, and which contribute to major fluid
shifts, as well as the aortic cross-clamping time, which
induces tissue ischaemia and cardiac stress.2,4,5
Since 1996, along with other authors, we have developed
minimally invasive laparoscopic or laparoscopy-assisted
techniques to decrease surgical aggression trauma as evi-
denced by shorter intensive care and hospital stays, asso-
ciated with a more rapid recovery.4e7 On the other hand,
despite the technical improvements made by the surgical
teams, the operative and aortic cross-clamping times
necessary for performing the laparoscopic aorto-prosthetic
anastomoses remain long in comparison with ‘open’
surgery, as confirmed by two recent comparative studies.8,9
As evidenced in the previous articles,10e12 we are
currently working to develop new laparoscopic instruments
to simplify these techniques and to decrease the long
learning curve. This study aims to establish the feasibility
and efficacy of a new clampless and sutureless device for
end-to-side aorto-prosthetic anastomosis. We decided to
perform this feasibility study initially with a conventional
open surgery, prior to the laparoscopic approach.
Material and Methods
The Clampless device (Figs. 1 and 2)
The device used in this study is under development within
the framework of a partnership between the ‘Universite´ de
la Me´diterrane´e’ and Protomed, a company headquartered
within our Faculty of Medicine. This device is a unit
composed of a vascular implant, named Clampless, and
a specific ancillary. More precisely, the implant is used to
perform a side-to-end aorto-prosthetic anastomosis and its
ancillary introduces and positions the implant in the
receiving artery and carries out anastomosis on the level of
this artery. The Clampless device is composed of
a vascular graft and a connector.In 25- to 33-kg pigs, the diameters of the infra-renal
aorta and iliac arteries are, respectively, 7e8 mm and
4e5 mm (Table 1). To fit these diameters, the Clampless
prototype implant is composed of:
 a 7-mm dedicated connector, an expandable balloon
and a stainless steel mesh covered with a polytetra-
fluoroethylene (PTFE) graft (this part of the implant
will remain inside the aorta); this is a tubular connector
and has a side opening to release a large lumen with
blood circulation into the bypass;
 a straight 5-mm PTFE vascular graft sutured to the side
of the connector using 7/0 polypropylene thread;
 a specific 7-mm balloon, which is included in the device
and which allows inflating the up- and downstream parts
of the connector simultaneously, ensures that it is sealed
between the aortic wall and the graft, forming the end-
to-side bypass anastomosis. After deflation, the balloon
is withdrawn through the 5-mm PTFE graft lumen;
 A 20 French (Fr.) ancillary introduction catheter that
allows introducing and delivering the Clampless
device into the receiving artery. This allows placing the
distal and proximal parts of the connector upstream
and downstream of the puncture point, respectively,
and allows using the connector to secure the
Table 1 Intra- and postoperative data after implantation of an aorto-iliac artery bypass using the Clampless device on
8 female pigs.
Pig # Intra-operative data Data at sacrifice
Weight
(Kg)
Aortic
diameter (mm)
Operative
time (min)
Proximal anastomosis
duration (min)
Blood
loss (ml)
Duration
(weeks)
Weight
(Kg)
Aortic
diameter (mm)
Angiogram
1 26 7 e e e 0(ID)a e e Graft
thrombosis
2 33 8 105 3.46 180 2 39 9 PGb
3 26 7 81 4.22 100 2 39 9 PG
4 29 8 102 2.25 150 0c e e PG
5 28 7 105 2.49 170 4 39 8 PG
6 31 7 115 4.50 200 4 46 10 PG
7 32 7 93 2.38 30 6 43 9 PG
8 25 7 104 4.18 235 6 42 10 PG
Mean 29 7 101 3. 35 152 e 41.3 9 e
a ID: intra-operative death due to a graft misplacement.
b PG: patent graft without stenosis.
c unrelated death caused by a pneumonopathy on D4.
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level of the artery puncture.
The Clampless device aims to create a vascular bypass
without cross-clamping and suturing. Simplified anasto-
mosis, no cross-clamping and reduced procedure time may
reduce the perioperative and/or postoperative risks and
complications. However, the system must be compatible
with traditional laparotomy, mini-laparotomy and complete
laparoscopic access.
In vivo animal experimental study
Eight 3-month-old female pigs, of a mean weight of 29 kg
(range: 25e33 kg), underwent implantation of an aortae
left iliac bypass using the Clampless device.
Surgical protocol
Animal care procedures complied with animal experimen-
tation legislation. The institutional Animal Use and Care
Committee reviewed and approved all the procedures and
protocols used in this study. All the pigs were operated
under general anaesthesia with endotracheal intubation. A
conventional transperitoneal surgical approach to the
abdominal aorta was performed with dissection of the first
5 cm of the left iliac artery. An intravenous injection of
100 UI kg1 of heparin was administered and the Clamp-
less device was implanted: after a single infra-renal aortic
puncture, a stiff guide wire was placed retroperitonially,
gradually introducing a 20 Fr. sheath into the 7- to 8-mm-
diameter aorta. The Clampless device was then inserted
and deployed through its ancillary, after removing the
sheath and guide wire. The flow through the 5-mm PTFE
graft implanted laterally was checked, as well as
a continuing pulse in the aorta below the graft. The graft
was then clamped and the ostium of the left iliac artery was
occluded with two clips. An end-to-end distal anastomosis
was performed conventionally between the graft and the
left iliac artery using a 7/0 polypropylene thread. An
angiogram was performed systematically at the end of theprocedure by direct puncture of the aorta above the
Clampless implantation. Finally, the retroperitoneal layer
and the abdominal wall were closed using running sutures.
A wound dressing was put into place and the animal was
allowed to emerge from anaesthesia under the care of
a veterinarian. During the postoperative period, each
animal received analgesic medication, antibiotics for 10
days and a daily subcutaneous injection of 3000 IU/0.3 ml
of low-molecular-weight heparin.
After 2, 4 or 6 weeks, the animals were sacrificed under
general anaesthesia. A re-do open transperitoneal
approach to the aorta was performed following another
angiogram, as previously described. The aorta (from above
the renal arteries to the iliac trifurcation) and the whole
PTFE graft including the distal anastomosis were carefully
removed and sent for pathological analysis. At the end of
the experiment, the animals were euthanaised by admin-
istering potassium chloride or KCl (40 mEq) intravenously.
Morphological analysis
All the samples were fixed in 4% formalin for 48 h. The
aorta, PTFE graft and Clampless device were opened along
their great axis, and macroscopic images were taken. The
metallic component of the Clampless device was carefully
removed. Specimen samples were taken along the PTFE-
covered portion of the aorta, in the aorto-prosthetic ostium
region and on the different anastomoses. Samples were
embedded in paraffin, and 5-mm sections were cut and
stained with haematoxylin and eosin (H&E).
Results
The intra-operative period
Feasibility
In the first pig, the Clampless device was not completely
inserted before removal of the introducer, which was
responsible for a tear in the aorta, with no possibility of
reintroducing the device. The animal was sacrificed and,
secondarily, a specific landmark was placed on the
600 Y.S. Alimi et al.Clampless device (on the part outside the introducer) to
prevent this problem. The seven other implantations were
uneventful with a mean operative time of 101 min (range:
81e115 min), and an anastomosis time of 3.35 min (range:
2.25e4.25 min), with good blood flow outside the PTFE
graft and a good pulse distally on the aorta (Table 1). All
the distal anastomoses on the left iliac artery were per-
formed conventionally without anomalies.
Impermeability
Spontaneous impermeability was satisfactory with no
leakage, except in one case, in which a 6/0 Prolene stitch
was necessary at the front part of the anastomosis, without
cross-clamping. Mean blood loss was 152 ml (range: 30e
235 ml) for the whole procedure.
Patency and angiographic control (Fig. 2)
The systematic angiogram performed at the end of the
procedure showed no blood leakage and a patent aorto-left
iliac bypass in all cases. No stenosis was noted either on the
Clampess implantation on the aorta or on the left iliac
artery, despite two cases of distal spasm with spontaneous
disappearance.
The surveillance period
All seven pigs had a normal postoperative recovery, except
one (#4), for whom the recovery period was long and
difficult. In the following days, this pig remained prostrated
without any ischaemic hindleg and good femoral pulses. On
the fourth postoperative day, this pig presented with whole
body tremor, a cold snout, hypothermia with an abnormal
auscultation of both lungs and died when brought to the
operating table. No control angiogram was then possible
but the whole abdominal aorta, the Clampless device and
the bypass were patent. The six other pigs had a normal
surveillance period, with a growth of a mean of 6, 11 and
17 kg, before the sacrifice of two of them at 2, 4 or 6
weeks, respectively.
Euthanasia and graft removal
No peri-aortic haematoma or false aneurysm was noticed in
any of the remaining six pigs during the abdominal re-Figure 3 Angiograms of the Clampless device (arrow) perforintervention. An angiogram was systematically performed
and showed no blood leakage and a patent aorto-left iliac
bypass in all cases, as well as both renal and iliac arteries,
and the inferior mesenteric artery. No stenosis was noted
either on the Clampess implantation on the aorta or on
the left iliac artery. However, due to the growth of the
animals, the diameter of the aorta increased and
a progressive discrepancy could be noticed between the
proximal and distal aorta compared to the intra-aortic part
of the Clampless device (Fig. 3).
Macroscopic examination
After removal of the aorta and the aorto-iliac bypass, no
anomaly was observed. There were no clots and thromboses
and the Clampless device was well inserted into the aortic
wall.
Microscopic examination
The tissue covering the intraluminal stent evolved over
time: at 2 weeks, this tissue was inconsistent and was
composed of fibrin associated with some endothelial cells;
at 4 weeks, it became a fragile tissue of variable thickness;
and at 6 weeks, the tissue was thick and continuous. There
were no visible signs of endothelial proliferation and
inflammation.
In the aortic wall under the stent graft, a localised
intimal necrosis with some calcifications, but without
modifications of the external layers, was noted at 2 weeks.
This fibrinous necrosis was progressively replaced at 4
weeks by a loose conjunctive tissue, with mild inflamma-
tion at 4 and 6 weeks. A macrophagic giant cell reaction
was noted in the periphery of the calcifications. A foreign
body granuloma had developed close to the PTFE graft
along its aortic wall without diffusion to the rest of the
aortic wall (Fig. 4).
Discussion
Patients presenting with the most severe forms of aorto-
iliac occlusive disease (TASC C and D lesions) and are also
generally elderly patients with severe risk factors and poor
cardio-respiratory conditions.2,3 As these patients, in line
with the TASC recommendations,1 are not good candidates
for endovascular techniques, there are a certain number ofmed during the initial procedure (A) and after 6 weeks (B).
Figure 4 Microscopic analysis of the tissue covering the
intraluminal stent evolves over time: A- at 2 weeks, fibrin
associated with some endothelial cells, B- at 4 weeks, there is
a fragile tissue with a variable thickness, C- at 6 weeks, there is
thick and continuous tissue.
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surgical treatment to the most fragile patients. To decrease
this aggressiveness, our team, with other authors, has tried
to develop minimally invasive video-assisted techniques.4e7
Our goal is to use a minimally invasive surgical approach to
minimise both large fluid shifts and hypothermia and to
avoid the aortic cross-clamping time, which induces tissue
ischaemia and cardiac stress. However, these two goals are not
compatible, as recently mentioned in two comparativestudies: in 2005, in the series by Rouers et al.,8 operative
and clamping times were significantly different in the group
of 28 patients who underwent conventional surgery for
AIOD compared to 30 patients treated with total laparo-
scopic surgery, with a mean aortic cross-clamp time
increasing from 17 to 66 min (p< 0.0001). This was
confirmed in the study by Kolvenbach et al. with a signifi-
cant increase in the mean cross-clamping time (from 25 to
45 min, p< 0.05) when comparing 187 patients treated with
the laparoscopy-assisted technique with a mini-laparotomy
and 105 patients who underwent a total laparoscopic
technique.9
Since Carrel’s pioneering work on vascular anastomosis,
a variety of alternative techniques have been developed to
perform an ideal anastomosis.13 As mentioned in a previous
article,12 rings, staples, clips, stents, adhesives or welding
have been tested as substitutes for needles and thread, but
most of these have had no clinical application.14e17 In the
present experimental study, the Clampless device allowed
to perform the same side-to-end aorto-prosthetic anasto-
mosis with a mean implantation time of 3.35 min, and
without aortic cross-clamping. The aortic dissection is also
simplified as there is no need to control the aorta above and
below the anastomotic site, but only to expose several
centimetres of the anterior part of the infra-renal aorta to
make possible both a puncture and the penetration of the
20 Fr. introducer. Interestingly, none of the angiograms
performed intra-operatively and during sacrifice showed
any graft thrombosis or stenosis, and the macroscopic and
microscopic examination after removal revealed good graft
implantation. Despite an aortic diameter up to 42% (from 7
to 10 mm) in 6 weeks, neither aortic bleeding nor false
aneurysm was noted.
Our study nevertheless deserves a certain amount of
criticism: first, the intra-operative death of the first pig was
due to insufficient spotting of the graft during implantation;
the addition of specific landmarks on the Clampless device
prevented this complication in the other seven pigs. Second,
the pigs’ rapid growth, with concomitant increase in the
native aortic diameter during the surveillance period, was
responsible for a progressive discrepancy with the implan-
ted stent at 2, 4 and 6 weeks; another animal model, such as
adult sheep, would have maintained the same aortic diam-
eter throughout the study. Finally, developing this first
prototype was not compatible with a laparoscopic implan-
tation, which remains our ultimate goal; in the initial
protocol, we wanted to be able to rapidly control any
bleeding, and also to choose the angle for introducing the
device into the aorta. In the future, we expect this device to
simplify the performance of a bypass on a visceral artery or
a unilateral aorto-femoral bypass. Hopefully, further
development of a bifurcated graft will allow an aorto-bife-
moral bypass to treat patients with severe AIOD. To adapt
Clampless to clinical use, the main body of these new
grafts will need to cover a range from 12 to 16 mm with
branches measuring 6e8 mm, and the delivering catheter
will probably need to be used through a 24 Fr. introducer, in
a 3- to 4 cm-long non-circumferentially calcified segment of
the infra-renal aorta. Furthermore, a laparoscopic implan-
tation will need improvements in delivering the catheter to
secure its use through a 12 mm trocar and to prevent blood
loss with a lower profile.18
602 Y.S. Alimi et al.Conclusion
We present a new clampless and sutureless device to
perform an end-to-side aorto-prosthetic anastomosis. The
present experimental study on eight pigs showed that the
implantation procedure was safe and efficient, with no
angiographic, macroscopic and microscopic anomalies after
a surveillance period of 2, 4 and 6 weeks. Further devel-
opments are needed for laparoscopic implantation to be
possible on larger aortas.
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